Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507440 · ClinicalTrials.gov registry record · Phase 4
Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's
A Phase 4 study of Topical Anesthesia, sponsored by Bassett Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02507440: Completed Phase 4 study of Topical Anesthesia, sponsored by Bassett Healthcare.
NCT02507440 is a Phase 4 study of Topical Anesthesia that has completed, run by Bassett Healthcare. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02507440, a Phase 4 study of Topical Anesthesia, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To find out if the administration of the local pharyngeal anesthetic, lidocaine, in conjunction with Propofol during elective Esophagogastroduodenoscopy (EGD) is useful, safe and impacts the time of discharge of patient compared to placebo.
Primary Outcome
The time from study drug administration to discharge from procedure area will be measured.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Lidocaine
- DRUG Propofol
Study Locations (1)
New York
- Bassett Healthcare Network - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
What the finished NCT02507440 record still lists
NCT02507440 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Topical Anesthesia appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02507440 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02507440 about?
NCT02507440 is a clinical study titled "Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's". To find out if the administration of the local pharyngeal anesthetic, lidocaine, in conjunction with Propofol during elective Esophagogastroduodenoscopy (EGD) is useful, safe and impacts the time of discharge of patient compared to placebo.
What is the current status of trial NCT02507440?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2015-09. Estimated completion is 2016-11.
What conditions does trial NCT02507440 study?
This clinical trial studies the following conditions: Topical Anesthesia.
What interventions are being tested in trial NCT02507440?
The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT02507440?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02507440 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02507440's enrollment target sits among peer trials
100 770th of 2000 higher than 1,149 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia